New perspectives on mannan-binding lectin-mediated complement activation
- PMID: 17544815
- DOI: 10.1016/j.imbio.2006.12.004
New perspectives on mannan-binding lectin-mediated complement activation
Abstract
The complement system is an important part of the innate immune system, mediating several major effector functions and modulating adaptive immune responses. Three complement activation pathways exist: the classical pathway (CP), the alternative pathway (AP), and the lectin pathway (LP). The LP is the most recently discovered, and least characterized. The CP and the LP are generally viewed as working through the generation of the C3 convertase, C4bC2b, and are here referred to as the "standard" pathways. In addition to the standard CP and LP, so-called bypass pathways have also been reported, allowing C3 activation in the absence of components otherwise believed critical. The classical bypass pathways are dependent on C1 and components of the AP. A recent study has shown the existence also of a lectin bypass pathway dependent on mannan-binding lectin (MBL) and AP components. The emerging picture of the complement system is more that of a small "scale-free" network where C3 acts as the main hub, than that of three linear pathways converging in a common terminal pathway.
Similar articles
-
Human astrovirus coat protein binds C1q and MBL and inhibits the classical and lectin pathways of complement activation.Mol Immunol. 2010 Jan;47(4):792-8. doi: 10.1016/j.molimm.2009.10.006. Epub 2009 Nov 6. Mol Immunol. 2010. PMID: 19896716
-
The down-stream effects of mannan-induced lectin complement pathway activation depend quantitatively on alternative pathway amplification.Mol Immunol. 2009 Dec;47(2-3):373-80. doi: 10.1016/j.molimm.2009.09.005. Epub 2009 Oct 1. Mol Immunol. 2009. PMID: 19800125
-
Activation of the alternative complement pathway by mannose-binding lectin via a C2-bypass pathway.Microbiol Immunol. 2011 Nov;55(11):817-21. doi: 10.1111/j.1348-0421.2011.00378.x. Microbiol Immunol. 2011. PMID: 21831201
-
Primitive complement system--recognition and activation.Mol Immunol. 2004 Jun;41(2-3):103-11. doi: 10.1016/j.molimm.2004.03.026. Mol Immunol. 2004. PMID: 15159055 Review.
-
Interaction of C1q and mannan-binding lectin with viruses.Immunobiology. 2002 Sep;205(4-5):563-74. doi: 10.1078/0171-2985-00155. Immunobiology. 2002. PMID: 12396016 Review.
Cited by
-
The Role of Complement Dysregulation in Glaucoma.Int J Mol Sci. 2024 Feb 15;25(4):2307. doi: 10.3390/ijms25042307. Int J Mol Sci. 2024. PMID: 38396986 Free PMC article. Review.
-
Regulation of humoral immunity by complement.Immunity. 2012 Aug 24;37(2):199-207. doi: 10.1016/j.immuni.2012.08.002. Immunity. 2012. PMID: 22921118 Free PMC article. Review.
-
Compstatin: a complement inhibitor on its way to clinical application.Adv Exp Med Biol. 2008;632:273-92. doi: 10.1007/978-0-387-78952-1_20. Adv Exp Med Biol. 2008. PMID: 19025129 Free PMC article. Review.
-
The association of HLA-DRB1 alleles and MBL2 gene variant in pediatric acute lymphoblastic leukemia patients.Hematol Transfus Cell Ther. 2024 Oct-Dec;46(4):327-334. doi: 10.1016/j.htct.2023.02.002. Epub 2023 Mar 21. Hematol Transfus Cell Ther. 2024. PMID: 37117150 Free PMC article.
-
Molecular defects in the mannose binding lectin pathway in dermatological disease: Case report and literature review.Clin Mol Allergy. 2010 Mar 25;8:6. doi: 10.1186/1476-7961-8-6. Clin Mol Allergy. 2010. PMID: 20338057 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
